Xenetic Biosciences, Inc.
XBIO
$3.02
-$0.12-3.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.11% | 67.21% | -18.79% | 16.15% | -3.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.11% | 67.21% | -18.79% | 16.15% | -3.45% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 18.11% | 67.21% | -18.79% | 16.15% | -3.45% |
| SG&A Expenses | -12.72% | 9.32% | -41.79% | -21.36% | -25.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.52% | 41.12% | -36.32% | -13.69% | -9.32% |
| Operating Income | 43.32% | -9.05% | 45.84% | 25.70% | 12.47% |
| Income Before Tax | 45.08% | -16.76% | 45.94% | 24.43% | 9.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.08% | -16.76% | 45.94% | 24.43% | 9.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.08% | -16.76% | 45.94% | 24.43% | 9.99% |
| EBIT | 43.32% | -9.05% | 45.84% | 25.70% | 12.47% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 61.16% | -16.77% | 45.98% | 24.51% | 10.19% |
| Normalized Basic EPS | 61.16% | -16.78% | 45.99% | 24.50% | 10.19% |
| EPS Diluted | 61.16% | -16.77% | 45.98% | 24.51% | 10.19% |
| Normalized Diluted EPS | 61.16% | -16.78% | 45.99% | 24.50% | 10.19% |
| Average Basic Shares Outstanding | 41.36% | 0.03% | 0.08% | 0.09% | 0.22% |
| Average Diluted Shares Outstanding | 41.36% | 0.03% | 0.08% | 0.09% | 0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |